TITLE

Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy

AUTHOR(S)
Ha Na Woo; Hye Kyung Chung; Eun Jin Ju; Joohee Jung; Hye-Won Kang; Sa-Won Lee; Min-Hyo Seo; Jin Seong Lee; Jung Shin Lee; Heon Joo Park; Si Yeol Song; Seong-Yun Jeong; Eun Kyung Choi
PUB. DATE
January 2012
SOURCE
International Journal of Nanomedicine;2012, Vol. 7, p2197
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
82508962

 

Related Articles

  • Combinatorial Nanoparticles for Cancer Diagnosis and Therapy. Mukerjee, A.; Ranjan, A. P.; Vishwanatha, J. K. // Current Medicinal Chemistry;Aug2012, Vol. 19 Issue 22, p3714 

    Nanotechnology when engineered together with biotechnology opens a fascinating field with applications in diverse areas such as drug targeting and delivery, medical imaging, biosensing, biomaterials and nanotechnology. Conjugating nanoparticles with biomolecules like QD-herceptin conjugates or...

  • Combinatorial Nanoparticles for Cancer Diagnosis and Therapy. Mukerjee, A.; Ranjan, A. P.; Vishwanatha, J. K. // Current Medicinal Chemistry;Aug2012, Vol. 19 Issue 23, p3714 

    Nanotechnology when engineered together with biotechnology opens a fascinating field with applications in diverse areas such as drug targeting and delivery, medical imaging, biosensing, biomaterials and nanotechnology. Conjugating nanoparticles with biomolecules like QD-herceptin conjugates or...

  • Targeting Nanoparticles as Drug Delivery Systems for Cancer Treatment. Subramani, Karthikeyan; Hosseinkhani, Hossein; Khraisat, Ameen; Hosseinkhani, Mohsen; Pathak, Yashwant // Current Nanoscience;May2009, Vol. 5 Issue 2, p135 

    This review article discusses about the current cancer treatment techniques and the extensive recent research studies done on nanoparticles as carrier systems for the delivery of anticancer drug molecules in cancer treatment. A variety of nanoparticles of different structural and chemical...

  • Effects of Carrier on Disposition and Antitumor Activity of Intraperitoneal Paclitaxel. M. Wientjes; Jessie Au // Pharmaceutical Research;Sep2007, Vol. 24 Issue 9, p1691 

    Abstract Purpose  The rationale for intraperitoneal (IP) chemotherapy is to expose peritoneal tumors to high drug concentrations. While multiple phase III trials have established the significant survival advantage by adding IP therapy to intravenous therapy in optimally debulked...

  • Development and Characterization of Solid-Lipid Microparticles of Highly Insoluble Drug Sirolimus. Nanjwade, Basavaraj K.; Patel, Didhija J.; Parikh, Kemy A.; Nanjwade, Veerendra K.; Manvi, F. V. // Journal of Bioequivalence & Bioavailability;2011, Vol. 3 Issue 1, p11 

    Solid lipid microparticles (SLMs) represent an alternative carrier system to traditional colloidal carrier such as emulsion, liposomes and polymeric micro and nanoparticles. The purpose of this research work was to develop and evaluate solid lipid microparticles of sirolimus for oral delivery....

  • The Drug Discovery by NanoMedicine and its Clinical Experience. Matsumura, Yasuhiro // Japanese Journal of Clinical Oncology;Jun2014, Vol. 44 Issue 6, p515 

    It is expected that the incidence of various adverse effects of anticancer agents maybe decreased owing to the reduced drug distribution in normal tissue. Anticancer agent incorporating nanoparticles including micelles and liposomes can evade non-specific capture by the reticuloendothelial...

  • Nanocarriers for Diagnosis and Targeting of Breast Cancer. Sharma, Arun; Jain, Nitin; Sareen, Rashmi // BioMed Research International;2013, Vol. 2013, p1 

    Breast cancer nanotherapeutics is consistently progressing and being used to remove the various limitations of conventional method available for the diagnosis and treatment of breast cancer. Nanoparticles provide an interdisciplinary area for research in imaging, diagnosis, and targeting of...

  • Nanoparticle-Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges. Babu, Anish; Templeton, Amanda K.; Munshi, Anupama; Ramesh, Rajagopal // Journal of Nanomaterials;2013, p1 

    The last decade has witnessed enormous advances in the development and application of nanotechnology in cancer detection, diagnosis, and therapy culminating in the development of the nascent field of "cancer nanomedicine" A nanoparticle as per the National Institutes of Health (NIH) guidelines...

  • Efficacy assessment of sustained intraperitoneal paclitaxel therapy in a murine model of ovarian cancer using bioluminescent imaging. Vassileva, V.; Moriyama, E. H.; De Souza, R.; Grant, J.; Allen, C. J.; Wilson, B. C.; Piquette-Miller, M. // British Journal of Cancer;12/16/2008, Vol. 99 Issue 12, p2037 

    We evaluated the pre-clinical efficacy of a novel intraperitoneal (i.p.) sustained-release paclitaxel formulation (PTXePC) using bioluminescent imaging (BLI) in the treatment of ovarian cancer. Human ovarian carcinoma cells stably expressing the firefly luciferase gene (SKOV3Luc) were injected...

  • Nano cancer therapy strategies. Tiwari, Manjul // Journal of Cancer Research & Therapeutics;Jan-Mar2012, Vol. 8 Issue 1, p19 

    Cancer is a leading cause of deaths. Millions of people are diagnosed with cancer every year. Many cancer cells have a protein all over their surface, while healthy cells typically do not express the protein as strongly. By conjugating, or binding, the gold nanoparticles to an antibody the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics